Yaz Remains Most Popular Female Contraceptive Despite Mounting Fatalities

 Yaz and Yasmin have recently become the subject of many class action lawsuits, as an increasing number of prescribed users are reporting mild to serious side effects from using the contraceptive medication. These “fourth generation” oral contraceptives both contain a synthetic variation of progestin known as drospirenone or dsrp. It is reported and alleged that dsrp is responsible for the number of fatal side effects caused by Yaz and Yasmin.

The usage of dsrp is believed to cause an increase in the body's levels of potassium - among other severe side effects - which if too high can cause an irregular heartbeat or cessation of heartbeats, both of which can be fatal. A dangerously high level of potassium can also cause disruption to the body's control over muscle and nerve function.

The use of oral contraceptives such as Yaz and Yasmin that include dsrp has been connected with several life threatening side effects including:

• Pulmonary embolisms

• Deep vein thrombosis

• Heart attack

• Stroke

• Gall bladder disease

• Kidney damage and failure

• Liver damage and failure

• Blood clots

• Sudden Death

When the body experiences an elevated level of potassium it is referred to as hyperperkalemia. Hyperperkalemia can lead to side effects and symptoms like nausea, diarrhea, constipation, heart palpitations, and more seriously, can lead to heart attacks if not treated. These are some of the most common types of fatalities that can allegedly be caused by the oral contraceptives Yaz and Yasmin.

However, fatalities caused by Yaz and Yasmin are not isolated to those involving cardiac arrest. In addition to fatalities caused by cardiac arrest and stroke, women that have taken either Yaz or Yasmin have experienced fatalities caused by pulmonary embolisms. To date over 100 injuries and fatalities caused by Yaz and Yasmin have been reported to the FDA. Over 50 fatalities were reported between 2001 and 2004. Fatalities caused by Yaz and Yasmin are not isolated to a specific age range or race. Injuries and fatalities caused by these oral contraceptives have fueled many large class action lawsuits against their manufacturer. Bayer, the company that manufactures both Yaz and Yasmin, continues to state that it will, "Defend itself vigorously."

Yaz and Yasmin remain some of the highest prescribed forms of oral contraception despite the known risks. Claims of injuries fatalities caused by Yaz and Yasmin seem to not have affected the ability for Bayer to sell the contraceptives.

Pending lawsuits regarding injuries and fatalities caused by the side effects of Yaz and Yasmin continue to mount. The basis of these lawsuits stems from the belief that Bayer used misleading and otherwise deceptive marketing tactics to sell Yaz and Yasmin. In fact, Bayer was required by the FDA to launch a new, more informative marketing campaign for Yaz and Yasmin. This marketing campaign cost Bayer over $20 million. Bayer has been warned repeatedly by the FDA in regards to the marketing tactics utilized for both Yaz and Yasmin. Bayer had claimed that both drugs could be used for the control of premenstrual syndrome, as well as mild to moderate acne.

However, Yaz and Yasmin had only undergone clinical testing regarding their effectiveness to treat premenstrual dysphoric disorder. PMS and PMDD are two different disorders. Also, Bayer neglected to warn physicians as well as the public of the increased risks associated to taking the drugs. It is believed that the consumption of dropspirenone presents a risk two-times greater than older means of contraception as far as blood clots are concerned. There is no mention of the risk of gall bladder disease, deep vein thrombosis, pulmonary embolism, or hyperperkalemia. The withholding of this information has lead to injuries and fatalities caused by Yaz and Yasmin.

With the surmounting number of class action lawsuits pertaining to wrongful death and fatality claims, there is yet to be a motion to ban Yaz and Yasmin. These forms of contraception are currently being prescribed despite mounting additions to the current class action lawsuit.

 

Page Type: 

You may also be interested in: